Site Search
Professionals 406 results
Capabilities 73 results
Practice Area
Our nationally recognized Appellate & Critical Motions (ACM) Practice delivers sophisticated legal advocacy and analysis before trial, at trial, and on appeal. From state trial courts to the U.S. Supreme Court, our ACM attorneys identify, preserve, and present the critical legal issues that can make the difference between winning and losing.
Europe
The transactional lawyers based in our London, Paris, and Brussels offices are seasoned practitioners with decades of experience advising on complex cross-border transactions. The long-established relationships we have cultivated with local counsel in countries across the continent, combined with our experience and demonstrated track record, makes us one of the go-to firms for cross-border corporate and finance transactions in Europe.
Practice Area
Representation & Warranty Insurance Claims
Winston is a market leader in the field of representation and warranty insurance (RWI) claims. With an in-depth understanding of the complexities and nuances of contractual agreements, we are skilled at meticulously analyzing purchase agreements, identifying potential breaches, and formulating comprehensive recovery strategies. This enables us to deliver favorable outcomes for our clients, making us a go-to-choice for buyers seeking preeminent counsel in this nuanced area of law.
Experience 478 results
Experience
|October 10, 2025
Winston Advises Vistria Affiliate in $136M IPO of Phoenix Education Partners
A Winston & Strawn LLP team led by partners Keerthika Subramanian, Steve Gavin and Timothy Kincaid and including Jacob Tabman, Jeremy Spankowski and Jenna Smith advised TVG-I-E-AEG Holdings, LP, an affiliate of The Vistria Group, as one of the selling stockholders in the $136 million initial public offering of Phoenix Education Partners, Inc. (NYSE: PXED), the parent company of The University of Phoenix, Inc. The IPO valued Phoenix Education Partners, Inc. at approximately $1.35 billion. The transaction marks The University of Phoenix’s return to public markets after nearly a decade as a private company.
Experience
|September 29, 2025
Winston Advises PJT Partners in Beyond Meat’s $1.105 Billion Exchange Offer
Winston & Strawn LLP represented PJT Partners in its role as dealer manager to Beyond Meat, Inc., a publicly traded food technology company and leading producer of plant-based meat alternatives, in connection with an exchange offer and consent solicitation for any and all of its $1.105 billion of 0% Convertible Senior Notes due 2027 for up to $202.5 million in new 7.00% Convertible Senior Secured Second Lien PIK Toggle Notes due 2030 and up to approximately 326 million shares of common stock.
Experience
|September 23, 2025
Denali Capital Acquisition Corp Closes Business Combination with Semnur Pharmaceuticals
Winston & Strawn LLP represented Denali Capital Acquisition Corp. (OTCQB: DNQAF), a special purpose acquisition company, in the closing of its previously announced business combination with Semnur Pharmaceuticals, Inc., a clinical late-stage specialty pharmaceutical company focused on the development and commercialization of novel non-opioid pain therapies and a majority-owned subsidiary of Scilex Holding Company (Nasdaq: SCLX).
Insights & News 7,767 results
Seminar/CLE
|January 22, 2026
14th ITA-IEL-ICC Joint Conference on International Energy Arbitration – Houston
Imad Khan is a proud Co-Chair of The Institute for Transnational Arbitration (ITA), Institute for Energy Law (IEL) and International Chamber of Commerce (ICC) International Court of Arbitration 14th edition of what has become the premier conference on international arbitration in the energy sector. Speakers from around the globe and across the industry will gather to focus on the key issues in the field today.
Sponsorship
|November 20, 2025
Winston & Strawn Sponsors 2025 Smart Business Dealmakers South Florida M&A Conference
Winston & Strawn is proud to sponsor the upcoming Smart Business Dealmakers South Florida M&A Conference. The conference brings together hundreds of local dealmakers, including middle-market CEOs, top investors and lenders, and leading M&A advisers.
Seminar/CLE
|November 13, 2025
AI in Action: Legal Strategies for Healthcare Innovation
We are bringing together stakeholders across the healthcare ecosystem—from front-line providers to financial backers—for a panel discussion on AI in healthcare.
Other Results 149 results
Law Glossary
What Is the Difference Between a Biosimilar and a Generic Drug?
A biosimilar is a biologic product that—as the name implies—is similar to its reference product. Because of a biologic’s complexity, it is not possible to synthesize identical biosimilars that are identical copies of their associated reference products.
Law Glossary
What Are the Patent Litigation Differences Between the BPCIA and Hatch-Waxman Act?
There are fundamental differences between the abbreviated approval processes to obtain FDA approval for biosimilars and generic drugs as those processes relate to patent litigation.
Site Content
Emerging technology is a term generally used to describe a new technology, but it may also refer to the continuing development of an existing technology; it can have slightly different meaning when used in different areas, such as media, business, science, or education. The term commonly refers to technologies that are currently developing, or that are expected to be available within the next five to ten years, and is usually reserved for technologies that are creating, or are expected to create, significant social or economic effects.